Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroprotective Agents | 11 | 2022 | 961 | 3.160 |
Why?
|
| Intracranial Hemorrhages | 7 | 2021 | 844 | 1.990 |
Why?
|
| Reperfusion Injury | 6 | 2022 | 1023 | 1.180 |
Why?
|
| NF-E2-Related Factor 2 | 4 | 2021 | 376 | 1.090 |
Why?
|
| Blood-Brain Barrier | 4 | 2019 | 1019 | 0.850 |
Why?
|
| Iron Chelating Agents | 2 | 2020 | 138 | 0.840 |
Why?
|
| Brain Ischemia | 8 | 2022 | 3127 | 0.800 |
Why?
|
| Brain Injuries | 5 | 2021 | 2044 | 0.750 |
Why?
|
| Endothelial Cells | 9 | 2021 | 3539 | 0.740 |
Why?
|
| Pericytes | 3 | 2019 | 293 | 0.670 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 119 | 0.620 |
Why?
|
| Intracellular Space | 1 | 2019 | 197 | 0.610 |
Why?
|
| Microvessels | 2 | 2017 | 572 | 0.530 |
Why?
|
| Oleanolic Acid | 1 | 2016 | 42 | 0.530 |
Why?
|
| Infarction, Middle Cerebral Artery | 6 | 2024 | 485 | 0.520 |
Why?
|
| Oligopeptides | 2 | 2020 | 1187 | 0.500 |
Why?
|
| Antioxidants | 4 | 2022 | 1667 | 0.480 |
Why?
|
| Stroke | 8 | 2024 | 9962 | 0.470 |
Why?
|
| Tetrazoles | 2 | 2017 | 905 | 0.460 |
Why?
|
| Aniline Compounds | 1 | 2019 | 1069 | 0.460 |
Why?
|
| Iron | 2 | 2020 | 1786 | 0.460 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 2023 | 1032 | 0.450 |
Why?
|
| Imidazoles | 1 | 2019 | 1180 | 0.440 |
Why?
|
| Disease Models, Animal | 17 | 2024 | 18137 | 0.390 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2050 | 0.330 |
Why?
|
| Cerebrovascular Circulation | 6 | 2023 | 2733 | 0.330 |
Why?
|
| Mitochondria | 3 | 2020 | 3600 | 0.300 |
Why?
|
| Mice | 25 | 2024 | 81208 | 0.300 |
Why?
|
| Warfarin | 1 | 2016 | 1518 | 0.280 |
Why?
|
| Triterpenes | 2 | 2018 | 81 | 0.280 |
Why?
|
| Cerebral Hemorrhage | 5 | 2023 | 2660 | 0.280 |
Why?
|
| Glucose | 3 | 2022 | 4351 | 0.280 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3387 | 0.270 |
Why?
|
| Oxygen | 2 | 2022 | 4193 | 0.270 |
Why?
|
| Carotenoids | 2 | 2020 | 620 | 0.270 |
Why?
|
| Animals | 31 | 2024 | 167963 | 0.270 |
Why?
|
| Reactive Oxygen Species | 5 | 2022 | 2138 | 0.260 |
Why?
|
| Brain | 10 | 2022 | 26951 | 0.250 |
Why?
|
| Behavior, Animal | 3 | 2021 | 1866 | 0.210 |
Why?
|
| Cyclodextrins | 1 | 2022 | 65 | 0.210 |
Why?
|
| Hemin | 2 | 2019 | 50 | 0.210 |
Why?
|
| Benzamidines | 1 | 2021 | 23 | 0.200 |
Why?
|
| Cell Death | 4 | 2020 | 1672 | 0.200 |
Why?
|
| Apoptosis | 6 | 2022 | 9501 | 0.190 |
Why?
|
| Guanabenz | 1 | 2021 | 6 | 0.190 |
Why?
|
| CADASIL | 1 | 2022 | 88 | 0.190 |
Why?
|
| Guanidines | 1 | 2021 | 193 | 0.180 |
Why?
|
| Brain Infarction | 2 | 2024 | 292 | 0.180 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2021 | 179 | 0.180 |
Why?
|
| Cells, Cultured | 5 | 2021 | 18957 | 0.170 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2020 | 239 | 0.170 |
Why?
|
| Clonidine | 1 | 2021 | 170 | 0.170 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2021 | 91 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2016 | 4897 | 0.170 |
Why?
|
| Cell Survival | 3 | 2021 | 5797 | 0.170 |
Why?
|
| Collagenases | 2 | 2017 | 221 | 0.170 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2019 | 11 | 0.170 |
Why?
|
| Ischemic Attack, Transient | 2 | 2023 | 901 | 0.170 |
Why?
|
| Hydrogen Peroxide | 2 | 2020 | 732 | 0.170 |
Why?
|
| Cortical Spreading Depression | 1 | 2023 | 288 | 0.170 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2019 | 24 | 0.170 |
Why?
|
| Ferrous Compounds | 1 | 2019 | 41 | 0.170 |
Why?
|
| Reperfusion | 1 | 2020 | 271 | 0.160 |
Why?
|
| Colony-Forming Units Assay | 1 | 2019 | 351 | 0.160 |
Why?
|
| Free Radical Scavengers | 1 | 2019 | 211 | 0.160 |
Why?
|
| Stem Cell Factor | 1 | 2019 | 196 | 0.160 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2019 | 202 | 0.160 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2017 | 296 | 0.150 |
Why?
|
| Hematoma | 2 | 2023 | 769 | 0.150 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2017 | 11 | 0.150 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 357 | 0.140 |
Why?
|
| Collagen Type IV | 1 | 2017 | 127 | 0.140 |
Why?
|
| Eye | 1 | 2021 | 710 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2019 | 23376 | 0.140 |
Why?
|
| Neurons, Afferent | 1 | 2019 | 498 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10446 | 0.130 |
Why?
|
| Random Allocation | 2 | 2017 | 2394 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2019 | 768 | 0.130 |
Why?
|
| Cerebral Infarction | 1 | 2020 | 982 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 697 | 0.130 |
Why?
|
| Eye Diseases | 1 | 2021 | 651 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2019 | 727 | 0.120 |
Why?
|
| Adiponectin | 1 | 2021 | 1115 | 0.120 |
Why?
|
| Hyperalgesia | 1 | 2019 | 530 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2022 | 1252 | 0.120 |
Why?
|
| Neurons | 3 | 2020 | 9426 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1871 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2021 | 1197 | 0.110 |
Why?
|
| Administration, Oral | 2 | 2020 | 4035 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2019 | 1521 | 0.110 |
Why?
|
| Male | 20 | 2024 | 359744 | 0.100 |
Why?
|
| Autophagy | 1 | 2020 | 1337 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2017 | 1167 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1182 | 0.100 |
Why?
|
| Mice, Inbred Strains | 3 | 2021 | 1763 | 0.100 |
Why?
|
| Hippocampus | 1 | 2024 | 3738 | 0.100 |
Why?
|
| Ischemia | 1 | 2020 | 1893 | 0.100 |
Why?
|
| Memory | 1 | 2021 | 2179 | 0.100 |
Why?
|
| Seizures | 1 | 2024 | 2917 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 2414 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 22023 | 0.090 |
Why?
|
| Cadherins | 1 | 2016 | 898 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 2693 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 867 | 0.090 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 2165 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2020 | 1879 | 0.090 |
Why?
|
| Xanthophylls | 2 | 2020 | 95 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1726 | 0.080 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4433 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2014 | 1112 | 0.080 |
Why?
|
| Cell Line | 2 | 2019 | 15620 | 0.070 |
Why?
|
| Humans | 17 | 2023 | 760621 | 0.070 |
Why?
|
| Blood Flow Velocity | 2 | 2021 | 1377 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16939 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2020 | 3484 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2016 | 4000 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 10182 | 0.050 |
Why?
|
| Oxidative Stress | 3 | 2018 | 3106 | 0.050 |
Why?
|
| Rodentia | 1 | 2023 | 260 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11481 | 0.050 |
Why?
|
| Infusions, Parenteral | 1 | 2021 | 399 | 0.050 |
Why?
|
| Rats | 3 | 2023 | 23711 | 0.050 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 364 | 0.040 |
Why?
|
| Laboratories | 1 | 2023 | 462 | 0.040 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 196 | 0.040 |
Why?
|
| Papilledema | 1 | 2021 | 130 | 0.040 |
Why?
|
| Maze Learning | 1 | 2021 | 477 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 8986 | 0.040 |
Why?
|
| Thrombin | 1 | 2021 | 593 | 0.040 |
Why?
|
| Cell Movement | 2 | 2021 | 5206 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 509 | 0.040 |
Why?
|
| Motor Activity | 2 | 2020 | 2687 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2021 | 632 | 0.040 |
Why?
|
| Protoporphyrins | 1 | 2018 | 165 | 0.040 |
Why?
|
| Retinal Neovascularization | 1 | 2021 | 273 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 1313 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2021 | 1126 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 1722 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2022 | 743 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2018 | 364 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2016 | 412 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 594 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 1553 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2019 | 1850 | 0.030 |
Why?
|
| Nociceptors | 1 | 2019 | 457 | 0.030 |
Why?
|
| Organelle Shape | 1 | 2014 | 2 | 0.030 |
Why?
|
| Retinal Vessels | 1 | 2021 | 836 | 0.030 |
Why?
|
| Premedication | 1 | 2015 | 253 | 0.030 |
Why?
|
| Time Factors | 3 | 2021 | 40165 | 0.030 |
Why?
|
| Protective Agents | 1 | 2015 | 150 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 704 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2016 | 177 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2017 | 379 | 0.030 |
Why?
|
| Brain Edema | 1 | 2018 | 603 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5201 | 0.020 |
Why?
|
| Homeostasis | 1 | 2022 | 3306 | 0.020 |
Why?
|
| Retina | 1 | 2021 | 2635 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 3484 | 0.020 |
Why?
|
| Zebrafish | 1 | 2020 | 2997 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7588 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10827 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 2488 | 0.020 |
Why?
|
| Research Design | 1 | 2023 | 6180 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8313 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2016 | 2985 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2014 | 1380 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20080 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15289 | 0.010 |
Why?
|
| Pain | 1 | 2019 | 5066 | 0.010 |
Why?
|
| Cognition | 1 | 2021 | 6957 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13502 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11903 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 54303 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13630 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29932 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 36290 | 0.010 |
Why?
|
| Female | 2 | 2024 | 391270 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65017 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29658 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 169152 | 0.010 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_